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Wnt signalinggoverning stem cell self-renewal and differentiation. In this review, we first summarize the
biological characteristics of seven types of dental stem cells, including dental pulp stem cells,
stem cells from apical papilla, stem cells from human exfoliated deciduous teeth, dental fol-
licle precursor cells, periodontal ligament stem cells, alveolar bone-derived mesenchymal
stem cells (MSCs), and MSCs from gingiva. We then focus on how these stem cells are regulated
by bone morphogenetic protein (BMP) and/or Wnt signaling by examining the interplays be-
tween these pathways. Lastly, we analyze the current status of dental tissue engineering stra-
tegies that utilize oral/dental stem cells by harnessing the interplays between BMP and Wnt
pathways. We also highlight the challenges that must be addressed before the dental stem
cells may reach any clinical applications. Thus, we can expect to witness significant progresses
to be made in regenerative dentistry in the coming decade.
Copyright ª 2016, Chongqing Medical University. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).Introduction
Tooth decay and tooth loss are common dental disorders.
There is an increasing clinical need to develop predictable
and effective therapeutic strategies to regenerate dental
tissues and restore their morphology and functions.1,2 Thus,
dental tissue engineering is an attractive therapeutic
strategy that complements traditional restorative tech-
niques and benefits from recent advances in stem cell
biology, molecular biology, genomics, and proteomics.3 One
of the most important components of successful regener-
ative dentistry involves in the use of adequate stem cells
that are stimulated with appropriate biological factors for
tissue/lineage-specific differentiation. Adult mesenchymal
stem cells (MSCs) have been isolated from tooth or tooth-
related tissues. Such repertoires of stem cells provide
gold opportunity for effective regeneration of oral tissues.4
In this review, we aim to provide an overview of the current
knowledge of utilizing dental stem cells and harnessing the
crosstalk between bone morphogenetic protein (BMP) and
Wnt signaling pathways as novel and efficacious therapeutic
strategies in dental tissue regeneration.Tooth development and dental stem cells
Tooth development
Teeth arise from sequential and reciprocal interactions
between oral ectoderm-derived oral epithelium and un-
derlying cranial neural crest (CNC)-derived mesenchyme.5
Tooth-specific hard tissues include enamel, dentin and
cementum, which are formed by differentiated amelo-
blasts, odontoblasts and cementoblasts at the junction
between the epithelium and mesenchyme (Fig. 1). The
earliest morphological sign is the primary dental lamina
giving rise to a thickening oral epithelium at the site of the
future tooth row, which is followed by formation of dental
placodes along the dental lamina.
During early tooth development, interactions between
oral epithelium and underlying mesenchyme govern dental
morphogenesis through successive bud, cap and bell
stages.6 Then, the tooth formation shifts from oralepithelium to underlying mesenchyme prior to the bud
stage.7 The inner dental epithelial cells differentiate into
enamel-producing ameloblasts. The dental papilla mesen-
chymal cells differentiate into dentin-secreting odonto-
blasts, while the remaining dental papilla cells (DPCs) form
dental pulp.7 Mechanistically, the differentiation of ame-
loblasts and odontoblasts are a well-coordinated process
(Fig. 1).
Once the crown is formed, root formation begins in most
teeth with the formation of cementum by dental follicle
mesenchyme-derived cementoblasts. Both root elongation
and tooth eruption require resorption of surrounding alve-
olar bone.6 Eventually, majority of epithelial tissue is lost
when teeth erupt into oral cavity and reach final length.
Interestingly, the rodent incisor grows continuously
throughout the life, although the regenerative capacity of
mammalian teeth is generally limited. Continuous growth
of the incisor throughout life requires adult epithelial stem
cells that give rise to enamel-forming ameloblasts,8 and
MSCs that lead to the dentin and cementum
regeneration.9e11
The soft-hard tissue connection of periodontal liga-
mentecementum complex (PLCC) is originated from in-
teractions between epithelial cells of Hertwig’s epithelial
root sheath (HERS) and mesenchymal cells of dental follicle
(DFCs).12 DFCs surrounding enamel organ differentiate into
cementoblasts that line the root, as well as fibroblasts and
osteoblasts that generate the periodontal ligament and
alveolar bone supporting the tooth.13 Thus, reciprocal in-
teractions between epithelial and mesenchymal compart-
ments are critical for tooth morphogenesis and
maintenance of dental stem cell niches.
Dental stem cells
Epithelial and mesenchymal cells are necessary to produce
a new functional tooth (Fig. 1).14 Cells forming the tooth
are derived from ectodermal epithelium and neural crest
ectomesenchyme.15 During development and regeneration,
the stem cells derived from ectodermal epithelium give rise
to ameloblasts and produce enamel after the first round of
dentin formation by odontoblasts (Fig. 1). Neural crest
ectomesenchyme stem cells consist of dental-derived MSCs
Figure 1 Anatomical locations of different types of dental stem cells in deciduous tooth (A) and permanent tooth (B). DPSCs,
dental pulp stem cells; SCAP, stem cells from apical papilla; SHED, stem cells from human exfoliated deciduous teeth; DFPCs,
dental follicle precursor cells; PDLSCs, periodontal ligament stem cells; ABMSCs, alveolar bone-derived mesenchymal stem cells;
and GMSCs, MSCs from gingiva.
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which possess the capacity for dental and periodontal
regeneration under certain conditions.16 Subsets of neural
crest-derived cells (NCDCs) also remain as stem cells into
adulthood.17 NCDCs in adults may be used as a stem cell
source for tissue regeneration.Dental-derived mesenchymal stem cells (DMSCs)
DMSCs are isolated from various dental tissues (Fig. 1).
These cells can undergo multi-lineage differentiation
including osteogenic and odontogenic differentiation,
providing an alternative source of MSCs for tissue engi-
neering.18 Although DMSCs present some common markers,
such as CD105, CD146 and STRO-1, stem cells derived from
various tissues exhibit heterogeneous capabilities of pro-
liferation, clonogenicity, and differentiation potential
in vitro and in vivo.19 Currently, DMSCs populations are
composed of at least seven types of stem cells: (a) dental
pulp stem cells (DPSCs), (b) stem cells from apical papilla
(SCAP), (c) stem cells from human exfoliated deciduous
teeth (SHEDs), (d) dental follicle precursor cells (DFPCs),
(e) periodontal ligament stem cells (PDLSCs),19e24 (f)
alveolar bone-derived MSCs (ABMSCs), and (g) MSCs from
gingiva (GMSCs) (Fig. 1).25
(1) DPSCs are multipotent stem cells that reside in the
cell-rich zone of both adult pulp tissue and deciduous
tooth pulp and apical papilla.26,27 DPSCs can be
readily isolated from discarded or removed teeth,
offering a promising and attractive source of autolo-
gous stem cells.28 They can differentiate along mul-
tiple cell lineages and promote the regeneration of
dental pulp, dentin, and cementum,29 such as the
generation of complete or partial tooth structures asbiological implants.28 DPSCs can also actively prolif-
erate, repair bone and give rise to other tissues.30,31
Interestingly, human DPSCs also exhibit major neu-
roregenerative activities, demonstrating that tooth-
derived stem cells may provide therapeutic benefits
for treating spinal cord injury.32 Nonetheless, it was
postulated that dental pulp may be the only source of
progenitor cells with dentinogenic potential for
regenerating dentinepulp complex.33
(2) SCAPs are isolated from soft tissue at the apices of
developing permanent teeth and share significant
similarities with DPSCs. Clinical attempts to preserve
the remaining DPSCs and SCAPs lead to canal revas-
cularization and completion of root maturation in
young permanent teeth.31
(3) SHEDs are derived from the pulp tissue of an exfoli-
ating deciduous tooth. They represent a postnatal
stem cell population with high proliferative capacity,
easy accessibility, high viability and multi-lineage
differentiation potential (e.g., osteoblasts, neural
cells, and odontoblasts).34,35 Therefore, SHEDs have
been widely used for oromaxillofacial bone
regeneration.36
(4) DFPCs are derived from ectomesenchymal tissue
surrounding enamel organ and dental papilla of
developing tooth prior to eruption.37 DFPCs are po-
tential stem cells for cementoblasts, osteoblasts and
periodontal ligament cells. They interact with HERS
cells during tooth root formation.38 When co-cultured
with HERS cells, DFPCs exhibited a greater tendency
to form mineralized nodules and higher levels of
cementoblast/osteoblast differentiation.12
(5) PDLSCs are derived from DFPCs and are isolated from
the mixed cell populations in the periodontal liga-
ment space. Human PDLSCs possess high osteogenic
and cementogenic differential ability.37
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progenitor cells of alveolar osteoblasts.37
(7) GMSCs are ideal stem cells for repairing damaged
periodontal tissues, muscle, and tendon,25 although it
remains unclear if PDLSCs and GMSCs could form a
dentinepulp-like structure.Non-dental-derived mesenchymal stem cells
(NDMSCs)
The main stem cell populations of NDMSCs include BMSCs,20
MSCs from peripheral nerve-associated glia, adipose tissue-
derived MSCs (ADSCs), and induced pluripotent stem cells
(iPSCs).39e42 BMSCs exhibit capacity for adipogenic and
osteogenic differentiation.43 Additionally, they have
demonstrated the ability to undergo odontogenic differ-
entiation in the context of a pulp extracellular matrix (ECM)
scaffold.44 Peripheral glial cells can produce pulp cells and
odontoblasts.45 ADSCs are particularly attractive and have
been shown to differentiate into teeth, bone, or
cartilage.46
Oral stem and mucosal cells may also serve as an ideal
source for reprogrammed cells including iPSCs.34,47,48 iPSCs
have characteristics similar to embryonic stem cells, and
the use of patient-derived iPSCs may avoid host immuno-
logical rejection and ethical controversy.49 Thus, successful
generation of iPSCs would provide great promise in the
development of regenerative medicine, including tooth
regeneration.50
Differentiation and immunomodulatory properties
of MSCs
As dental stem cells share many characteristics with those
of MSCs, there has been considerable interest in their wider
applications to treat disorders using mesenchymal cell de-
rivatives.28 Dental stem cells express various markers pre-
viously thought to be specific for MSCs, embryonic stem
cells and neural cells.23 In addition, other embryonic stem
cell features have been reported in both DPSCs and SHEDs
although specific conditions to maintain the ability of
DMSCs to initiate whole tooth formation may be required.51
These cells have a vast repertoire of differentiation (e.g.,
osteogenic, odontogenic, adipogenic, and neurogenic), and
are even capable of generating corneal cells and pancreatic
islet cells,52 endothelial cells,53 and dentinepulp com-
plex.25 The tooth must be vascularized, innervated and
appropriately anchored in the bone,14 while pulp revascu-
larization is dependent on the differentiation capability of
residual pulp and apical and periodontal stem cells.54 When
stimulated with Wnt1, the DPSCs were prone to neural
differentiation and expressed higher levels of neurogenic
markers.55
These MSC-like cells exhibit some unique characteris-
tics, including immunomodulatory properties56 and para-
crine processes.57 MSCs, including those of dental origin,
can host immune response58e60 by inhibiting T cells,
inducing regulatory T cells and converting dendritic cells
(DCs) and macrophages into regulatory phenotype. MSCs
were shown to inhibit cell proliferation of T cells, B cells,natural killer (NK) cells and DCs, leading to division arrest
anergy.58e60 Moreover, MSCs can inhibit a variety of other
immune cell functions.61
BMP signaling in dental stem cells
BMPs and BMP receptors (BMPRs) regulate the development
of calcified tissues by directing mesenchymal stem cell
differentiation.62e68 A complex network of BMP signaling
pathways and transcription factors regulates the differen-
tiation of MSCs during development and throughout adult-
hood. These signaling pathways include BMP, Wnt, sonic
hedgehog (Shh), Notch, fibroblast growth factor (FGF), and
retinoic acid pathways, and the homeobox gene super-
family, which are key players in epithelial-mesenchymal
signaling loops driving tooth development.69,70
BMPs signaling mechanism in dental stem cells
BMPs belong to the TGF-b superfamily of proteins,68,71 and
play a critical role in skeletal development and stem cell
differentiation. More than 20 BMP-like molecules have been
identified in vertebrates and invertebrates,5,72 several of
which are of great importance to dental engineering. TGF-
b/BMP plays an essential role in bone development by
activating BMP receptor (BMPR) serine/threonine kinases.68
Mutations of TGF-b/BMP activity are linked to many clinical
disorders, such as skeletal, extra skeletal anomalies,
autoimmune, cancer, and cardiovascular diseases. Tooth
development requires synchronous and spatially different
BMPs expression and interaction.73
BMPs exert their biological functions through both ca-
nonical and non-canonical pathways. In the canonical
signaling pathway, BMPs initiate the signal transduction
cascade by binding to BMPRs and forming a hetero-
tetrameric complex comprised of two dimers of type I and
type II serine/threonine kinase receptors.71 There are
seven type I receptors (ALK1-7) for the TGF-b family of li-
gands, three of which bind BMPs: type 1A BMPR (BMPR-1A or
ALK3), type 1B BMPR (BMPR-1B or ALK6), and type 1A
activin receptor (ActR-1A or ALK2).74 The heterotetrameric
signaling complex formation can vary and is less well
defined. For example, BMP6 and BMP7 interact with BMPR-2
and recruit BMPR-1, whereas BMP2 and BMP4 preferentially
bind BMPR-1 and recruit BMPR-2.75 Phosphorylation of TGF-
b (I/II) or BMPRs activates Smads. The signaling network in
skeletal development and bone formation is complex and
tempo-spatial specific.76
BMP signaling plays an essential role in early tooth
development and disruptions of BMP signaling cause early
arrested tooth development.77 The essential role of BMPR-
1A and BMPR-1B in tooth development is demonstrated in a
tissue-specific manner.78 CNC-specific inactivation of BMPR-
1A arrests tooth development at the bud/early cap
stages.78 Substitution of BMPR-1A by constitutively active
form of BMPR-1B in neural crest cells rescues molar and
maxillary incisor development although the rescued teeth
exhibit delayed odontoblast and ameloblast differentia-
tion.78 BMPR-1B, -2, and the ActR-1 are detected in dental
follicular and HERS cells at day 6 of periodontal develop-
ment and later more diffusely in the periodontium,79 while
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tent with a report indicating that STRO-1 positive DFCs may
be targets of BMPs secreted by HERS.79
While BMP signaling plays a pivotal role in craniofacial
organ and tooth development, canonical BMP signaling may
not operate in early developing tooth. Although pSmad1 is
highly expressed in the dental follicle, HERS, and the
periodontium,79 the absence of pSmad1/5/8-Smad4 com-
plex may be caused by saturation of Smad4 by pSmad2/3 in
the dental mesenchyme.77 Silencing Smad2/3 or over-
expression of Smad4 leads to the formation of pSmad1/5/8-
Smad4 complexes, and subsequently activates canonical
BMP signaling in dental mesenchymal cells.77
BMPs are potent regulators of not only bone, but also
cartilage formation and repair, cell proliferation during
development and adult bone homeostasis.80 In tooth
development, tight regulation of BMPR-1A signaling is
essential.81 Juglone-mediated inhibition of PIN1 augments
the osteogenic medium (OM)-induced activation of BMPs,
Wnt/b-catenin, ERK, JNK, and nuclear factor-kappa B (NF-
kB) pathway, suggesting that PIN1 may function as an
important modulator of odontogenic and adipogenic dif-
ferentiation of DPSCs.82 However, these odontogenic and
osteogenic effects by BMPs can be reversed by deletion of
key regulators in BMPs signaling pathways. First, deletion of
Smad4 leads to defective odontoblast differentiation and
dentin formation.83 Melatonin-induced BMP2 expression
and Smad1/5/8 phosphorylation can be blocked by noggin.
Furthermore, melatonin activates p38MAPK, ERK, and NF-
kB in hDPSCs, and these actions can be attenuated by in-
hibitors of BMP.84
BMP signaling is modulated by various factors and
pathways.76 ADSCs from caALK2þ/mice had increased BMP
signaling and activated pSmad 1/5.85 Mothers against Smad
and MAPK pathways are also involved in BMP signaling, and
their actions are regulated by intracellular and extracel-
lular proteins and small molecules. Extracellular phosphate
(Pi) regulates BMP2 expression via cAMP/PKA and extra-
cellular signal-regulated kinase (ERK)1/2 pathways in
human DPSCs.86 Negative regulators of BMP signaling can
block the signal transduction at multiple levels, including
decoy receptors, inhibitory intracellular binding proteins,
and inducers of BMP ubiquitination.87 Furthermore, several
non-canonical, Smad-independent signaling pathways for
BMPs have been identified. For example, BMP4 was found to
activate TAK-1 signaling.88 It has also been demonstrated
that BMPR-1 and BMP2 may principally regulate Fshb
expression in LbT2 cells via noncanonical activation of
Smad2/3 signaling.89Diverse roles of BMPs in regulating osteogenic/
odontogenic differentiation
BMP2 can give rise to osteogenic and odontogenic differ-
entiation in autologous or allogeneic DMSCs/NDMSCs-based
engineering dentistry. BMP signaling was shown to signifi-
cantly accelerate in SHEDs.90 BMP2 has been used as a
surface coating on scaffolds, decreasing pore size and
causing better adhesion and reduced proliferation of BMP-
MSCs.91 Recombinant human (rh)BMP2 is effective in
establishing complete regeneration of a boney defect by4e6 months, as assessed by intraoperative observations and
histologic studies.92 Histomorphometric analysis indicates
that the use of rhBMP2 in bone repair without the use of
bone grafting materials should offer new strategies for
osseous reconstruction of facial bone defects.92 Osteogenic
differentiation in 3D micro-tissues is enhanced by strong
integrin-ECM interactions and by stronger autocrine BMP2
signaling.93 BMP2 has been detected in HERS cells, dental
follicular cells, and in differentiated periodontal cells.79
Local application of BMP4 in epithelium of molar terri-
tories either stimulates Islet1 expression, while inhibition
of BMP signaling results in a loss of Islet1 expression.94 BMP7
has been detected in HERS cells, dental follicular cells, and
in differentiated periodontal cells.79
Through a comprehensive analysis of the 14 types of
human BMPs, we demonstrated that BMP9 (aka, GDF2) is
one of the most potent BMPs in promoting osteoblastic
differentiation of MSCs both in vitro and
in vivo.62,63,66,68,95,96 Nonetheless BMP9 is one of the least
studied BMPs and we have demonstrated that BMP9 in-
teracts with ALK1 and ALK2 type I receptors97 and upre-
gulates a panel of critical downstream mediators that are
involved in promoting the early stage of progenitor
expansion and then late stage of terminal osteogenic dif-
ferentiation of MSCs.98e103 For example, we demonstrated
that growth hormone (GH) is a direct early target of and
upregulated by BMP9 signaling.102 Furthermore, exogenous
GH synergizes with BMP9 on inducing osteogenic differ-
entiation through insulin-like growth factor 1 (IGF1)
signaling, which can be significantly blunted by JAK/STAT
inhibitors.102 One potential mechanistic explanation of
BMP9’s potent osteogenic activity is that BMP9 can out-
compete BMP antagonist noggin much more effectively
than other osteogenic BMPs such as BMP2, BMP4, BMP6 and
BMP7.104 Furthermore, we demonstrated that BMP9 syn-
ergizes with several important signaling pathways,
including Wnts, IGFs, EGF, Notch, and retinoic acid
signaling pathways, in promoting osteogenic differentia-
tion of MSCs.39,66,105e109 More recently, we demonstrated
that BMP9 effectively induces osteo/odontoblastic differ-
entiation of the stem cells of dental apical papilla
(SCAPs).110
As an inhibitor of bone formation, BMP3 expression can
be detected after day 13 of periodontal development. It is
conceivable that BMP3 may arrest of this process by
inhibiting cementogenic and osteogenic BMPs.79 Nonethe-
less, epithelial stem cell proliferation in cervical loops is
controlled by an integrated regulatory network consisting
of activin, BMPs, FGFs, and follistatin within incisor stem
cell niches.10 Mesenchymal FGF3 stimulates epithelial stem
cell proliferation, and BMP4 represses FGF3 expression.10
Activin inhibits the repressive effect of BMP4 and restricts
FGF3 expression to labial dental mesenchyme.10 Follistatin
limits the number of lingual stem cells and contributes to
the asymmetry of mouse incisors.10Wnt signaling in dental stem cells
Wnt family consists of at least 19 Wnt ligands encoded in
both human and mouse genomes. Wnts are secreted pro-
teins and are among the most potent factors regulating
Figure 2 Wnt and BMP signaling crosstalk in regulating dental stem cell proliferation and differentiation. Green lines indicate
stimulatory effects while black lines indicate inhibitory actions.
268 F. Zhang et al.stem cell self-renewal and have tremendous potential for
promoting human tissue regeneration111e115 (Fig. 2). Wnt
signaling regulates cell proliferation, migration, differen-
tiation, apoptosis, and in epithelial-mesenchymal in-
teractions involved in dental and periodontal tissue
morphogenesis.116 Wnt responsiveness in the craniomax-
illofacial tissues was mapped and the patterns of Wnt
signaling co-localize with stem cell populations in rodent
incisor apex, dental pulp, alveolar bone, periodontal liga-
ment, cementum, and oral mucosa.117
Wnts are secreted lipid-modified glycoproteins and
short-range ligands to activate canonical and noncanonical
signaling pathways.115,118 The hallmark of canonical
pathway is the activation of b-catenin-mediated tran-
scriptional activity (Fig. 2). The canonical pathway is
initiated by binding of Wnt ligand to receptor complex
containing Frizzled (Frz) protein and co-receptor of low
density lipoprotein receptor-related protein (LRP)5/6.
Binding of Wnts to Frz and LRP-5/6 activates distinct
signaling pathways.105,115,118 Mutations in LRP-5 adversely
affect skeletal development and bone mass.119
Ligandereceptor interaction is transmitted through
Dishevelled (Dsh) proteins, leading to the inhibition of a
multiprotein complex containing proteins Axin, APC, PP2A,GSK3, and casein kinase 1a.115,120 Without ligand binding,
this complex facilitates phosphorylation of b-catenin,
resulting in its degradation via ubiquitineproteasome
pathway. Thus, Wnt binding leads to an increase in cyto-
plasmic and nuclear b-catenin level, which complexes with
T cell factor/lymphoid enhancer factor (TCF/LEF) tran-
scription factors and other co-activators,121,122 regulating
downstream target genes.115,118,123e125
Many extracellular secreted inhibitors can modulate Wnt
signaling by binding either to Wnt ligands, e.g., Wif and
secreted frizzled-related protein (SFRP), or co-receptors
LRP5/6 (e.g., Dkk, Wise/Sost).121
Canonical Wnt signaling regulates tooth number in mice
and humans, while its role in tooth replacement remains to
be elucidated.118 Canonical Wnt target genes (e.g., Lef1
and Axin2) are continuously expressed in dental lamina tip
and surrounding mesenchymal cells.126 Canonical Wnt ac-
tivity was shown to extend instead of thickening the python
dental lamina.126 We found that the canonical Wnt/b-cat-
enin signaling pathway plays a critical role in BMP9-induced
osteogenic differentiation of MSCs.105 BMP9-induced
ectopic bone formation and matrix mineralization are
significantly inhibited by both FrzB overexpression or b-
catenin knockdown,105 suggesting that the canonical Wnt/
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osteogenic signaling.
The non-canonical Wnt signaling of the planar cell po-
larity (PCP) pathway does not depend on b-catenin activity
and is thought to transduce through NRH1, Ryk, PTK7, or
ROR2 without interacting with LRPO5/6.118 The PCP
pathway is also activated via the binding of Wnt to Frz and
its co-receptor. The receptor complex then recruits Dsh to
interact with Dsh-associated activator of morphogenesis 1
(DAAM1). DAAM1 activates small G-protein Rho and then
Rho-associated kinase (ROCK). Dsh also forms a complex
with Rac1 and mediates profilin binding to actin. Rac1 ac-
tivates JNK and leads to actin polymerization.112,127 None-
theless, it remains to be fully investigated whether non-
canonical Wnt signaling plays any important roles in tooth
development and in regulating the proliferation and dif-
ferentiation of dental stem cells.Crosstalk between Wnt and BMP signaling
pathways in dental stem cells
Dedicatedly regulated interactions between epithelial and
mesenchymal tissue components of developing teeth
govern tooth morphogenesis and determine the key fea-
tures of dentitions and individual teeth.128 The develop-
ment of individual tooth involves signaling networks,
particularly in the BMP and Wnt signal pathways through
positive and negative feedback loops (Fig. 2).129
At embryonic age (E) 9.5 days, BMP4 expression is
detected in the epithelium of the dental lamina, follicle
and papilla and decreases rapidly on E10.5 or E11.5. BMP2
expression is not prominent until E13.5, after which signal
is widespread throughout the neural-crest mesenchyme.130
BMP4 was shown to induce a translucent mesenchymal zone
similar to that induced by dental epithelium, supporting a
role of BMP4 in regulating epithelial-mesenchymal in-
teractions during early tooth development.131
Msx, BMP, LEF1, and Activin bA were shown to co-express
in coincidence of tooth phenotypes in knockout mice. Msx1
is required for BMP4 expression transition from dental
epithelium to mesenchyme and for LEF1 expression.132
Induced activity of canonical Wnt, FGF, and Shh signaling
pathways rescues development of arrested mouse dia-
stemal tooth germs as it was reported that BMP4 and Msx1
act in a positive feedback loop to drive sequential tooth
formation.133
Physical interaction between Wise, an extracellular
protein that binds BMP ligands, and Wnt-modulator LRP4
acts as a direct link the two pathways at extracellular level.
Mutations in either Wise or LRP4 in mice produced similar
abnormalities in tooth development that are associated
with alterations in BMP and Wnt signaling.134 During tooth
development, LRP4 is expressed exclusively in epithelial
cells while Wise mainly in mesenchymal cells. Wise and
LRP4 act together to coordinate BMP and Wnt signaling
activities in epithelial-mesenchymal cell communication
during development.134 Thus, LRP4 modulates and in-
tegrates BMP and canonical Wnt signaling during tooth
development by binding Wise.135
During tooth and jawbone formation, TGFb/BMP
signaling regulates the fate of multipotent CNC cells anddirects these cells differentiating into odontoblasts and
osteoblasts. Deleting Smad4 led to defects in odontoblast
differentiation and dentin formation and upregulation of
canonical Wnt signaling,83 indicating that Smad4 critically
regulates crosstalk between TGFb/BMP and Wnt signaling to
ensure proper CNC cell fate.
Using iSCAP cells, we found that Wnt3A effectively
induced early osteogenic markers, which was reduced by b-
catenin knockdown.136 While Wnt3A and BMP9 synergisti-
cally induced ALP activity in iSCAPs, knocking-down b-cat-
enin diminished BMP9-induced osteo/odontogenic
differentiation.136 Furthermore, the iSCAPs stimulation
with both BMP9 and Wnt3A exhibited more mature and
highly mineralized trabecular bone, while knockdown of b-
catenin in iSCAPs reduced BMP9 or BMP9/Wnt3A-induced
ectopic bone formation in vivo,136 suggesting that b-cat-
enin may play an important role in BMP9-induced osteo/
odontogenic signaling.
It has been shown that over-activation of the Wnt/b-
catenin pathway delays differentiation and growth of inner
dental epithelium, resulting in adult teeth presenting with
altered size, morphology and mineralization due to
delayed differentiation and prolonged proliferation of the
dental mesenchyme.137 BMPR-1A depletion at differentia-
tion stage switches differentiation of crown epithelia to
root lineage, giving rise to ectopic cementum-like struc-
tures.138 This phenotype is related to activated Wnt/b-
catenin signaling and epithelial-mesenchymal transition
(EMT). Epithelial b-catenin depletion during differentiation
stage causes variable enamel defect and precocious/
ectopic formation of fragmented root epithelia.138
Concomitant epithelial b-catenin depletion was shown to
rescue EMT and ectopic cementogenesis caused by BMPR-
1A depletion, suggesting that BMP and Wnt/b-catenin
pathways interact antagonistically in regulating root line-
age differentiation and EMT.138 Thus, proper crosstalk be-
tween BMP and Wnt signaling pathways is essential for
tooth development.
Dental and periodontal tissue engineering
The current status
Tissue engineering in regenerative medicine is a thera-
peutic approach to restoring or repairing the functions of
defective or damaged tissues through the use of scaffolds,
signaling molecules, and progenitor cells.19 The applica-
tions of effective regenerative approaches in dental clinics
can potentially significantly improve patients’ quality of
life.139e141
Although current tissue engineering technology and the
discovery of dental stem cells allow for regenerating pulp
and dentin,142 the development of reproducible animal
models is essential to assess the efficacy and success of
dental regeneration in vivo.143 Nonetheless, several pre-
clinical human models demonstrated the potential utility
of tissue engineering-based strategies in regenerating
pulpedentin complex, particularly for necrotic or immature
permanent teeth.144 A recent study using pulpal MSCs
showed promising results in pulpedentin regeneration
in vivo through autologous transplantation,145 reinforcing
270 F. Zhang et al.the notion that DPSCs may be used for successful dental
tissue engineering.146
Regeneration of dental pulp de novo has proved difficult
as the tissue is encased in dentin and is without collateral
blood supply except from the root apical end. However,
recent advances in this field may provide realistic means of
replacing lost or damaged teeth.147 Tooth enamel is inca-
pable of self-repairing, but dentin and cementum can
naturally regenerate with limited capacity. Regeneration of
dentin depends on pulp tissue and the source of odonto-
blastic stem cells.142 Recombinant human BMP7 and human
TGF-b3 have been shown to induce cementogenesis and
generate functionally oriented periodontal ligament fibers
and interweaving Sharpey’s fibres in non-human primate
Class II and III furcation defects.73
Current preclinical studies have indicated that cell-
based tissue engineered constructs induce more robust
bone formation when compared with acellular con-
structs.148 The advent of iPSC technology generates much
of the excitement in dental/periodontal tissue engineering
and regenerative medicine.149 iPSCs show great promise in
dental applications due to their proliferation and differ-
entiation capacities, although it requires rigorous evalua-
tion of their specificity and safety prior to any use in
patients.150 The potential of iPSCs to aid in the develop-
ment of new treatments for various diseases is exciting, and
researchers are only beginning to discover their potential
benefits for humans. We recently demonstrated that
conditionally immortalized SCAPs (iSCAPs) not only main-
tain long-term cell proliferation but also retain the ability
to differentiate into multiple lineages, including osteo-
blasts and odontoblasts in vivo.110 Thus, iSCAPs may serve
as an important tool to study SCAP biology and SCAP
translational use in tooth engineering.110BMPs in dental tissue engineering
While the scaffolds and progenitor cells are critical com-
ponents of tissue engineering, the addition of signal mole-
cules, such as BMPs and Wnts, has proven more effective in
promoting periosteal-mediated bone regeneration and
dental/periodontal regeneration.151,152 Successful extrac-
tion of growth factors and BMPs from mammalian teeth may
offer an important alternative for effective tooth
engineering.64,153
During crown formation, BMP2 is known as an inducer for
tooth development. It was shown that BMP2 can accelerate
amelogenesis.154 Furthermore, there is a positive feedback
mechanism linking some microRNAs, such as miR-200c and
miR-203, and BMP signaling through regulating the expres-
sion of E-cadherin, amelogenin, and/or BMP antagonist
BMPer.8 BMP4 is secreted by MSCs and regulates cell dif-
ferentiation in the dental epithelium during crown forma-
tion.155 Mesenchymal BMP4 participates in signaling within
the dental epithelium and maintains Shh and BMP2
expression in Msx1 mutant dental epithelium.156 During
tooth development, HERS cells participate in root forma-
tion following crown development.157 BMP4-positive cells
are detected in dental papillae around HERS.155 BMP4 is co-
expressed with Sox2158 and the mesenchymally expressed
BMP4 promotes elongation and maintaining cellproliferation of HERS cells, suggesting BMP4 may be used as
a root-formation agent in tissue engineering applica-
tions.155 SHED cells transmit BMP signals through both the
Smad and p38MAPK pathways.159 Furthermore, BMP9 may
be explored as a novel and efficacious osteogenic agent for
odontogenic regeneration.110
BMPs within a collagenous matrix carrier are capable of
inducing cementum and alveolar bone regeneration in the
furcation defect model of non-human primates.160
Morphological analysis of the resulting tissue reveals peri-
odontal ligament formation and insertion of Sharpey’s fi-
bers into cementum.160
Low doses of BMP2 in combination with physiological
doses of dexamethasone, ascorbic acid, beta-
glycerophosphate, heparin, retinoic acid and vitamin D
accelerate osteogenesis of mouse and human MSCs.161,162
BMP7-transduced MSCs, AdBMP7 co-delivered with
AdLMP3, or BMP7-transduced human oral keratinocyte cells
are all also able to accelerate bone formation.163e165 A
comprehensive analysis of BMPs in bone formation identi-
fied BMP9 as the most osteogenic BMP and may present a
more effective strategy for the augmentation of bone
regeneration than the BMPs currently used in the clinical
setting.66Wnt signaling molecules in dental tissue
engineering
The canonical Wnt signaling pathway plays an important
role in tooth development.137,166 When tooth replacement
is initiated, Wnt/b-catenin activity is presented in the
budding successional lamina and adjacent mesenchyme but
no active FGF signaling.158 Interestingly a novel insertion/
frameshift mutation in BMP target gene Runx2 caused a
typical cleidocranial dysplasia (CCD) phenotype, altered
the biological function of Runx2(þ/m) MSCs and the reduced
ability of MSCs to differentiate into osteoblasts may explain
defects of bone and teeth in CCD patients.167
During Wnt-induced enamel formation, Pitx2/b-catenin
regulatory pathway is involved in epithelial cell differen-
tiation and conversion of mesenchymal cells to amelogenin-
expressing epithelial cells via miR-200a.168 Pitx2 activates
miR-200a-3p expression and miR-200a-3p reciprocally re-
presses Pitx2 and b-catenin expression. Pitx2 and b-catenin
interact to synergistically activate gene expression during
odontogenesis, and miR-200a-3p attenuates their expres-
sion and directs differentiation.168 Furthermore, Wnt acti-
vation is associated with superior pulp healing as pulp cells
responded to Wnt stimulus by differentiating into secretory
odontoblasts, improving pulp vitality and formation of more
tertiary dentin.169
Hydroxyapatite bioceramics with micro-nano-hybrid
surface (mnHA) was shown to stimulate gene expression
of LRP5 and b-catenin in human PDLSCs.170 Moreover, the
stimulatory effect of mnHA bioceramics on ALP activity and
cementogenic gene expression was repressed by Dkk1.170
Conditional knockout of b-catenin in developing odonto-
blasts and cementoblasts resulted in rootless molars and
incomplete incisors, indicating Wnt/b-catenin signaling is
critical for root odontogenesis and cementogenesis.171
Wnt and BMP signaling in regenerative dentistry 271Wnt3a is expressed in HERS during mouse tooth root
development but not in cultured dental mesenchymal
cells.12 Pretreatment of cells with Dkk-1 markedly attenu-
ated Wnt3a-induced ALP expression.12 Furthermore, Wnt3a
induces Runx2 and osterix at gene and/or protein levels in
HERS, suggesting that HERS may play an important role in
stimulating cementoblast/osteoblast differentiation of
DFCs via the Wnt/b-catenin signaling pathway.38
Conversely, Dkk1 was shown to promote cementogenic
differentiation of ADSCs.172 Activation of endogenous ca-
nonical Wnt signaling with LiCl was shown to inhibit
cementoblast differentiation and promote cell
proliferation.173
Wnt/b-catenin upregulates the expression of dentine
sialophosphoprotein, osteocalcin and ALP in SCAPs after
incubation with mineralization induction medium, sug-
gesting that canonical Wnt/b-catenin signaling may pro-
mote odonto/osteogenic differentiation of SCAPs.136,174
Nonetheless, non-canonical Wnt5a was shown to stimulate
hADSC osteogenic differentiation.175 Interestingly, a
blockade of canonical Wnt signaling by Dkk1 led to osteo-
genic differentiation of PDLSCs under inflammatory condi-
tions, but activation by Wnt3a increased osteogenic
differentiation of BMSCs.43 Differentiation of dentin matrix-
treated DFCs was enhanced by Wnt3a when in direct con-
tact with HERSCs, indicating HERSCs induce osteogenic
differentiation of DFCs involving Wnt signaling and dentin
matrix during tooth root formation.12
Activation of Wnt signaling by acetylsalicylic acid, which
also upregulates the telomerase reverse transcriptase
(TERT), improved SHED-mediated bone regeneration.36
Down-regulated anti-differentiation noncoding RNA
(ANCR) promoted proliferation and osteogenic differentia-
tion of PDLSCs while inhibition of canonical Wnt signaling
also inhibited the osteogenic differentiation of PDLSCs/
ANCR-RNAi cells, demonstrating that ANCR is a key regu-
lator of PDLSC proliferation and osteogenic differentiation,
and its function is regulated by canonical Wnt signaling.176
Nevertheless, activation of ERK1/2 signaling by bFGF in-
hibits Wnt/b-catenin pathway and causes osteogenic defi-
ciency of SHEDs, which was rescued by ERK1/2 inhibitors.177
It should be pointed out that a long-term aberrant
activation of Wnt signaling, such as by expression of a
stabilized form of b-catenin in Sox2-positive postnatal
dental epithelial stem cells, was shown to induce odon-
toma, which contains multiple tooth-like structures and all
dental tissue layers.178 Activation of Wnt signaling in Sox2-
positive embryonic progenitor cells promoted odonto-
genesis throughout the oral cavity.178 Thus, certain pre-
cautions should be exercised when using canonical Wnt
signaling molecules in tooth tissue engineering.Concluding remarks and future directions
Our understanding of oral stem cells has expanded signifi-
cantly for the past decade. Nonetheless, limited numbers
of clinical trials are currently underway to evaluate the
potential use of stem cells in the treatment of oral and
dental diseases.25 While there is a great need to establish
cost-effective and safe protocols for exploiting DMSCs and
NDMSCs in clinical use,49 significant challenges must beaddressed before the dental stem cells reach any clinical
applications. The advantages for using dental tissue-
derived stem cells for tooth regeneration include highly
accessible attainment, reproducibility, capability of self-
renewal and large-scale expansion, less immune rejec-
tion, avoidance of ethical controversy, and readiness for
making iPCSs. However, the generation of fully functional
teeth from the oral progenitor cells remains an elusive
long-term goal. Future investigations should be directed to
address the following questions: How can we efficiently and
reproducibly isolate and maintain dental stem cells in cul-
ture? How can effectively and safely expand the isolated
stem cells? What are the exact mechanisms underlying BMPs
or Wnts’ functions in regulating dental stem cell prolifer-
ation and differentiation? Can Wnt-BMP cross-talk be
further exploited in order to establish potent and syner-
gistic biofactors for dental regeneration? What are the
biocompatible scaffold materials that can be used for
biofactor-programmed stem cell therapies for regenerative
dentistry? We may expect to get some satisfactory answers
to these questions in next 5e10 years.Conflicts of interest
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